RxDoctor Payments Data

Kellie Wendzinski, DO

Family Medicine · Grosse Pointe Park, MINPI 1710500640

Payments from drug & device makers

$1,417in general payments, 2019–2025

Across 24 payments — averaging $59.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$361
  • Amgen$262
  • Novo Nordisk$135
  • AstraZeneca$128
  • E.r. Squibb & Sons, L.L.C.$125
  • Grifols USA, LLC$124
  • plus $281 from 8 others

What the payments were for

  • Food & beverage$1,40699%
  • Education$111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,417 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$9,625
Medicare patients
30
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide16$15,421
Rosuvastatin Calcium29$680
Tamsulosin Hcl13$447
Atorvastatin Calcium44$429
Losartan Potassium27$282
Cyclobenzaprine Hcl14$264
Sertraline Hcl12$215
Omeprazole15$208
Metformin Hcl34$165
Fluticasone Propionate17$156
Lisinopril16$155
Gabapentin18$144
Amlodipine Besylate28$120
Trazodone Hcl16$102
Levothyroxine Sodium12$60

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$135$15,42116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Grosse Pointe Park

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →